353 related articles for article (PubMed ID: 15585889)
1. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.
Wei Y; Chen K; Sharp GC; Braley-Mullen H
J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis.
Wei Y; Chen K; Sharp GC; Yagita H; Braley-Mullen H
J Immunol; 2001 Dec; 167(11):6678-86. PubMed ID: 11714840
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis of thyrocytes and effector cells during induction and resolution of granulomatous experimental autoimmune thyroiditis.
Tang H; Chen K; Wei Y; Sharp GC; McKee L; Braley-Mullen H
Int Immunol; 2000 Dec; 12(12):1629-39. PubMed ID: 11099302
[TBL] [Abstract][Full Text] [Related]
4. Murine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis in DBA/1 mice.
Fang Y; Wei Y; Demarco V; Chen K; Sharp GC; Braley-Mullen H
Am J Pathol; 2007 Mar; 170(3):875-87. PubMed ID: 17322373
[TBL] [Abstract][Full Text] [Related]
5. FLIP and FasL expression by inflammatory cells vs thyrocytes can be predictive of chronic inflammation or resolution of autoimmune thyroiditis.
Wei Y; Chen K; Sharp GC; Braley-Mullen H
Clin Immunol; 2003 Sep; 108(3):221-33. PubMed ID: 14499245
[TBL] [Abstract][Full Text] [Related]
6. Expression of transgenic FLIP on thyroid epithelial cells inhibits induction and promotes resolution of granulomatous experimental autoimmune thyroiditis in CBA/J mice.
Fang Y; DeMarco VG; Sharp GC; Braley-Mullen H
Endocrinology; 2007 Dec; 148(12):5734-45. PubMed ID: 17823262
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of spontaneous resolution versus fibrosis in granulomatous experimental autoimmune thyroiditis.
Chen K; Wei Y; Sharp GC; Braley-Mullen H
J Immunol; 2003 Dec; 171(11):6236-43. PubMed ID: 14634140
[TBL] [Abstract][Full Text] [Related]
8. Induction of experimental autoimmune thyroiditis in IL-12-/- mice.
Chen K; Wei Y; Sharp GC; Braley-Mullen H
J Immunol; 2001 Aug; 167(3):1720-7. PubMed ID: 11466396
[TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis.
Batteux F; Lores P; Bucchini D; Chiocchia G
J Immunol; 2000 Feb; 164(4):1681-8. PubMed ID: 10657610
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells.
Braley-Mullen H; McMurray RW; Sharp GC; Kyriakos M
Cell Immunol; 1994 Feb; 153(2):492-504. PubMed ID: 8118878
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis.
Fang Y; Sharp GC; Braley-Mullen H
Am J Pathol; 2008 Jun; 172(6):1591-602. PubMed ID: 18467701
[TBL] [Abstract][Full Text] [Related]
13. Balance of proliferation and cell death between thyrocytes and myofibroblasts regulates thyroid fibrosis in granulomatous experimental autoimmune thyroiditis (G-EAT).
Chen K; Wei Y; Sharp GC; Braley-Mullen H
J Leukoc Biol; 2005 Feb; 77(2):166-72. PubMed ID: 15536125
[TBL] [Abstract][Full Text] [Related]
14. Effect of transgenic overexpression of FLIP on lymphocytes on development and resolution of experimental autoimmune thyroiditis.
Fang Y; Sharp GC; Braley-Mullen H
Am J Pathol; 2011 Sep; 179(3):1211-20. PubMed ID: 21763264
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC; Tang H; Chen K; Kyriakos M; Bickel JT
Am J Pathol; 1998 May; 152(5):1347-58. PubMed ID: 9588903
[TBL] [Abstract][Full Text] [Related]
16. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
17. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis.
Stassi G; Todaro M; Bucchieri F; Stoppacciaro A; Farina F; Zummo G; Testi R; De Maria R
J Immunol; 1999 Jan; 162(1):263-7. PubMed ID: 9886394
[TBL] [Abstract][Full Text] [Related]
18. Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.
Uchiyama H; Kishihara K; Minagawa R; Hashimoto K; Sugimachi K; Nomoto K
Immunology; 2002 Apr; 105(4):450-7. PubMed ID: 11985665
[TBL] [Abstract][Full Text] [Related]
19. Significant role for Fas in the pathogenesis of autoimmune diabetes.
Su X; Hu Q; Kristan JM; Costa C; Shen Y; Gero D; Matis LA; Wang Y
J Immunol; 2000 Mar; 164(5):2523-32. PubMed ID: 10679090
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts.
Tourneur L; Malassagne B; Batteux F; Fabre M; Mistou S; Lallemand E; Lores P; Chiocchia G
J Immunol; 2001 Aug; 167(3):1338-46. PubMed ID: 11466351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
